A patient is described with light chain myeloma and amyroidosis in whom 2 unusual complications occurred, diffuse osteolytic lesions and tetany. These observations extend the previously recognized clinical spectrum of this disorder.
Introduction
Widespread osteolytic lesions and hypercalcaemia are common in patients with all forms of malignant plasma cell dyscrasias, including light chain myeloma. However, in the sub-group of patients with light chain myeloma and amyloidosis the occurrence of radiographically evident lytic bone disease is rare. We wish to report an unusual case of systemic light chain myeloma in which tetany, related to small bowel amyloid, and diffuse skeletal disease coexisted.
Case report
A 58-year-old woman was admitted to hospital with a 2-week history of diarrhoea, weight loss and back pain. Skeletal radiographs revealed widespread lytic bone lesions, diffuse osteopenia, pathological rib fractures and spinal collapse (Fig. 1) 
Discussion
There are 2 remarkable features of this case, firstly the occurrence of diffuse skeletal lesions in association with amyloidosis in light chain myeloma, and secondly, the occurrence of tetany despite extensive malignant bone resorption.
Although radiographically apparent osteolytic lesions occur in approximately 65% of all patients with light chain myeloma, this is an uncommon finding when there is evidence of associated amyloidosis. Bone lesions are also rare in primary amyloidosis (Khojasteh, Arnold and Farhangi, 1979 ) and the clinical presentation of patients with amyloid secondary to plasma cell dyscrasia is usually with amyloidrelated, rather than skeletal, symptoms (Brandt, Cathcart and Cohen, 1968; Kyle and Bayrd, 1975 the study of Stone and Frenkel (1975) , only one of 7 patients with light chain myeloma and amyloidosis had radiographically apparent skeletal disease, and this was a solitary plasmacytoma. Our patient had diffuse osteopenia and pathological fractures of the vertebrae and ribs, suggesting advanced and aggressive osteolysis. It is not known why this common complication of myeloma should afflict this group so infrequently. However, the survival of these patients may be considerably shorter than that of patients with light chain myeloma without amyloidosis, so it may reflect the more aggressive nature and shorter duration of the disease (Stone and Frenkel, 1975; Shustik, Bergsagel and Pruzanski, 1976) . Hypercalcaemia occurs frequently in myeloma, particularly where there is radiographically overt bone disease and renal impairment. In contrast, hypocalcaemia is uncommon and tetany has, to our knowledge, never been reported (Drivsholm, 1964; Kyle, 1975) . Many factors seem likely to have contributed to the development of tetany. The low level of iPTH, despite severe hypocalcaemia, and the brisk response of serum calcium to magnesium infusion, suggest that magnesium deficiency was important. Hypomagnesaemia, which is a recognized complication of malabsorption, may cause tetany directly, but also acts indirectly by producing hypocalcaemia through impaired parathyroid hormone release and end-organ responsiveness (Rude, Oldham and Singer, 1976) . Malabsorption of vitamin D accompanied the fat malabsorption, since a 7-week course of oral vitamin D2 failed to bring serum 25-OHD levels to normal. Hypovitaminosis D would thus have contributed to calcium malabsorption, hypocalcaemia and tetany. The tetany was therefore attributable to the effects of malabsorption, which was presumably due to amyloid and light chain deposition in the small bowel.
These observations suggest that the clinical spectrum of light chain myeloma with amyloid may extend to both severe osteolytic bone disease and diarrhoeal tetany.
